Science on the Sly

A scientist at the University of Kansas Medical Center, Kansas City, Kans., pleaded guilty in May in a case involving theft of research materials from the Cleveland Clinic Foundation in Ohio. In a plea bargain with prosecutors, Hiroaki Serizawa, an assistant professor of biochemistry at KUMC, admitted he lied to FBI agents who were investigating the theft of DNA, cell line reagents, and other genetic research materials used in Alzheimer research at the Cleveland Clinic. Officials say that the 19

Written byTed Agres
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

Okamoto had been researching Alzheimer disease at the Cleveland Clinic from January 1997 to July 1999, when he abruptly resigned. According to a federal indictment, Okamoto stole several hundred vials containing cell line reagents and DNA samples, destroyed remaining materials and lab notes, and left behind mislabeled vials filled with tap water. Okamoto then shipped the stolen DNA and reagents to Serizawa for safekeeping.

In August, Okamoto retrieved the purloined materials from Serizawa and took them to the Institute of Physical and Chemical Research (RIKEN), a facility near Tokyo funded largely by the Japanese government and at which he had recently obtained a position as a neuroscience researcher. Okamoto has been charged with economic espionage, altering and destroying trade secrets, and interstate and international transfer of stolen materials. The Justice Department's request for Okamoto's extradition to face trial in the United States "is under consideration by the government of Japan," ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies